Drug Trial Radar · NCT02497469
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Jan 28, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
771
Actual
Start
Jun 29, 2015
Primary completion
Sep 26, 2018
Study completion Jan 18, 2019
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Jul 14, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) treatment over a 52-week treatment period.
Conditions
- Colitis, Ulcerative
Interventions
VedolizumabDrug
Vedolizumab infusion
Adalimumab placeboDrug
Adalimumab placebo-matching injection
AdalimumabDrug
Adalimumab injection
Vedolizumab placeboDrug
Vedolizumab placebo-matching infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved Clinical RemissionTime frame: Week 52
Locations
330 sites in 34 countries. Site status is shown where the registry gives one.
IMC - Diagnostic and Medical Clinic
Mobile, Alabama
Arizona Arthritis & Rheumatology Research, PLLC
Phoenix, Arizona
Arkansas Primary Care Clinic, PA
Little Rock, Arkansas
WCCT Global (PH 1 Unit)
Costa Mesa, California
California Medical Research Associates Inc.
Northridge, California
Sutter Institute for Medical Research
Sacramento, California
Rocky Mountain Gastroenterology
Lakewood, Colorado
Medical Research Center of Connecticut, LLC
Hamden, Connecticut
Innovative Medical Research of South Florida, Inc.
Aventura, Florida
Advanced Clinical Research of Miami
Doral, Florida
Wellness Clinical Research
Hialeah Gardens, Florida
Nature Coast Clinical Research, LLC
Inverness, Florida
Florida Center for Gastroenterology
Largo, Florida
Gastro Health
Miami, Florida
Medical Professional Clinical Research
Miami, Florida
Tellus Clinical Research, Inc.
Miami, Florida
South Florida Research Phase I-IV
Miami Springs, Florida
Gastroenterology Group of Naples
Naples, Florida
Internal Medicine Specialists
Orlando, Florida
BRCR Medical Center, Inc.
Plantation, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
Shafran Gastroenterology Center
Winter Park, Florida
Emory University Hospital
Atlanta, Georgia
Gastroenterology Associates of Central Georgia
Macon, Georgia
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
Carle Foundation Hospital
Urbana, Illinois
Gastroenterology of Southern Associates
New Albany, Indiana
Iowa Digestive Disease Center
Clive, Iowa
Cotton-O'Neil Clinical Research Center, Digestive Health
Topeka, Kansas
University of Louisville
Louisville, Kentucky
Research Concierge, LLC
Owensboro, Kentucky
Gastroenterology Associates, LLC
Baton Rouge, Louisiana
Lafayette General Medical Center
Lafayette, Louisiana
Clinical Trials Management, LLC
Metairie, Louisiana
Louisiana Research Center, LLC
Shreveport, Louisiana
Digestive Disease Associates
Catonsville, Maryland
Chevy Chase Clinical Research
Chevy Chase, Maryland
Clinical Research Institute of Michigan, LLC
Chesterfield, Michigan
Center for Digestive Health and Nutritional Excellence
Troy, Michigan
Showing 40 of 330 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.